The following is a list of studies performed which provide evidence of Theacrine's potential as an energy boosting supplement. The human trials listed were performed on the Teacrine form of Theacrine which we sell here.
This study was the most involved human trial of Theacrine (as Teacrine®) to date, and involved both single dose usage by some subjects and daily use over the course of 7 days by others.
Anchored VAS questionaires were used by subjects to report changes in their levels of physical and mental energy. In addition, subjects were monitored for any side effects, changes in hemodynamics, and other signs that Theacrine may pose a safety risk.
The study found Theacrine to be both safe and well tolerated and an effective energy boosting supplement.
Key Conclusions:
In this study, rats were injected with varying doses of Theacrine in order to assess its effects on their activity levels. Theacrine was also used in tandem with adenosine and dopamine receptor antagonists to examine whether or not Thearcine acts on those pathways.
Key Conclusions:
This study was conducted to examine the ability of Theacrine to reduce or prevent stress induced liver damage in mice. Stress was induced in mice that resulted in liver damage, some of these mice were given varying doses of Theacrine afterwords and it was found to reverse the signs of liver damage in the mice that it was administrered to.
In vitro ORAC and a cellular antioxidant activity assay was also performed, which found Theacrine to be a potent antioxidant though it achieved these effects not by purging free radicals directly but by causing an elevation in liver glutithione.
Key Conclusions:
In this study theacrine was tested on mice for possible anti-inflammatory and analgesic (pain reducing) effects. The study found that theacrine was effective both as an anti-inflammatory and analgesic supplement.
Key Conclusions:
In this study the effects of low dose Theacrine on the central nervous system were investigated. It was found to act as both a sedative and hypnotic at low doses.
Key Conclusions: